Medicines labeled for the same conditions
Alternatives to rimantadine
3 other medicines are given the same way (oral) and in the same FDA class as rimantadine or labeled mainly for the same use (influenza); 1 is in its class, influenza a m2 protein inhibitors: amantadine; the others include 1 neuraminidase inhibitor and 1 polymerase acidic endonuclease inhibitor (FDA labels read October 8, 2026). In the same class, the lowest pharmacy cost is $0.143 per amantadine 100 mg capsule (what pharmacies paid in the NADAC survey; strengths differ).
Which medicines are labeled for the same conditions as rimantadine?
Influenza lists all 5 medicines labeled for it, by any route. Each row shows the conditions both labels name. They are listed as public records, not as substitutes: whether one can replace another depends on the person and is a prescriber's decision.
| Medicine and FDA class | Shared indication | Generic labelers (oral) | Pharmacy cost | Boxed warning | Shortage |
|---|---|---|---|---|---|
| Rimantadineinfluenza a m2 protein inhibitor | this medicine | 1 labeler | n/a | No | No current entry |
| Amantadineinfluenza a m2 protein inhibitor · same class | Influenza | 34 labelers | $0.143 per capsule 100 mg capsule | No | No current entry |
| Oseltamivirneuraminidase inhibitor | Influenza | 36 labelers | $0.150 per mL 6 mg/mL suspension | No | No current entry |
| Baloxavir marboxilpolymerase acidic endonuclease inhibitor | Influenza | none listed | $161.94 per tablet 40 mg tablet | No | No current entry |
Source: FDA drug labels (indications) via openFDA; FDA NDC Directory; CMS NADAC of October 7, 2026; FDA Drug Shortage Database (FDA files October 8, 2026)
What do pharmacies pay for each?
The headline NADAC price per unit of each medicine's most widely listed form; strengths differ, so compare like with like on each record.
Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price
What next?
- Rimantadine: the full record
- label, generics, price, shortages, recalls